Results 161 to 170 of about 87,320 (219)

Anatomical and visual outcome of intravitreal bevacizumab (Avastin) in patients with diabetic macular edema

, 2016
Shyam Vyas, Raba Thapa, Sanyam Bajimaya, Eli Pradhan, Govinda Paudyal   +4 more
openalex   +2 more sources

Real-world outcomes of faricimab in treating diabetic macular edema up to two years. [PDF]

Indian J Ophthalmol
Khetan T, Shah P, Ahmed S, Jeyabaladevan P, Vithlani S.   +4 more
europepmc   +1 more source

Patient-Reported Visual Function Outcomes After Anti–Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal or Hemiretinal Vein Occlusion

, 2019
Ingrid U. Scott, Paul VanVeldhuisen, Franca B. Barton, Neal L. Oden, Michael S. Ip, Barbara A. Blodi, Martin Worrall, Gary E. Fish   +7 more
openalex   +2 more sources

Are statins a promising therapeutic strategy for macular edema? Insights from a systematic review and meta-analysis. [PDF]

Int J Retina Vitreous
Chen KY, Chan HC, Chan CM.
europepmc   +1 more source

The hidden companion: Vitreous cyst in retinitis pigmentosa with cystoid macular edema

Stuti Astir, Sandeep Kumar, Charu Gupta, Daraius Shroff   +3 more
openalex   +1 more source

Three-year outcomes of cystotomy and fibrinogen clot removal for diabetic macular edema with subfoveal cystoid macular edema. [PDF]

Sci Rep
Yamada H, Imai H, Sotani Y, Matsumiya W, Miki A, Kusuhara S, Nakamura M.   +6 more
europepmc   +1 more source

Faricimab as Treatment for Sarcoid Uveitis With Refractory Cystoid Macular Edema. [PDF]

J Vitreoretin Dis
Lin TH, Lin HY, Chuang YH, Tseng PC.
europepmc   +1 more source

Hyperreflective Dots on SD-OCT: Implications for Predicting Treatment Outcomes in Diabetic Macular Edema. [PDF]

Diagnostics (Basel)
Li S, Li M, Sun A, Zhang H.
europepmc   +1 more source

Predictive value of uninterrupted dry macula duration for discontinuation of anti-VEGF therapy in diabetic macular edema. [PDF]

Sci Rep
Murata T, Hirano T, Ideta S, Tanaka K, Shimura M.   +4 more
europepmc   +1 more source

Cataract surgery and the risk of developing recurrence or progression of diabetic macular edema. [PDF]

PLoS One
Kim M, Park YG, Park YH.
europepmc   +1 more source